Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes von Sobral-Leite, Marcelo, Salomon, Izhar, Opdam, Mark, Kruger, Dinja T, Beelen, Karin J, van der Noort, Vincent, van Vlierberghe, Ronald L P, Blok, Erik J, Giardiello, Daniele, Sanders, Joyce, Van de Vijver, Koen, Horlings, Hugo M, Kuppen, Peter J K, Linn, Sabine C, Schmidt, Marjanka K, Kok, Marleen

Volltext

Expression of HLA Class I Antigen, Aspirin Use, and Survival After a Diagnosis of Colon Cancer von Reimers, Marlies S, Bastiaannet, Esther, Langley, Ruth E, van Eijk, Ronald, van Vlierberghe, Ronald L. P, Lemmens, Valery E. P, van Herk-Sukel, Myrthe P. P, van Wezel, Tom, Fodde, Riccardo, Kuppen, Peter J. K, Morreau, Hans, van de Velde, Cornelis J. H, Liefers, Gerrit Jan

Volltext

Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia von Peirs, S, Frismantas, V, Matthijssens, F, Van Loocke, W, Pieters, T, Vandamme, N, Lintermans, B, Dobay, M P, Berx, G, Poppe, B, Goossens, S, Bornhauser, B C, Bourquin, J-P, Van Vlierberghe, P

Volltext

MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia von Mets, E, Van der Meulen, J, Van Peer, G, Boice, M, Mestdagh, P, Van de Walle, I, Lammens, T, Goossens, S, De Moerloose, B, Benoit, Y, Van Roy, N, Clappier, E, Poppe, B, Vandesompele, J, Wendel, H-G, Taghon, T, Rondou, P, Soulier, J, Van Vlierberghe, P, Speleman, F

Volltext

PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis von Garcia, E. G., Veloso, A., Oliveira, M. L., Allen, J. R., Loontiens, S., Brunson, D., Do, D., Yan, C., Morris, R., Iyer, S., Garcia, S. P., Iftimia, N., Van Loocke, W., Matthijssens, F., McCarthy, K., Barata, J. T., Speleman, F., Taghon, T., Gutierrez, A., Van Vlierberghe, P., Haas, W., Blackburn, J. S., Langenau, D. M.

Volltext

Long noncoding RNA signatures define oncogenic subtypes in T-cell acute lymphoblastic leukemia von Wallaert, A, Durinck, K, Van Loocke, W, Van de Walle, I, Matthijssens, F, Volders, P J, Avila Cobos, F, Rombaut, D, Rondou, P, Mestdagh, P, Vandesompele, J, Poppe, B, Taghon, T, Soulier, J, Van Vlierberghe, P, Speleman, F

Volltext

NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC... von Clappier, E, Collette, S, Grardel, N, Girard, S, Suarez, L, Brunie, G, Kaltenbach, S, Yakouben, K, Mazingue, F, Robert, A, Boutard, P, Plantaz, D, Rohrlich, P, van Vlierberghe, P, Preudhomme, C, Otten, J, Speleman, F, Dastugue, N, Suciu, S, Benoit, Y, Bertrand, Y, Cavé, H

Volltext

Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia von Durinck, K, Van Loocke, W, Van der Meulen, J, Van de Walle, I, Ongenaert, M, Rondou, P, Wallaert, A, de Bock, C E, Van Roy, N, Poppe, B, Cools, J, Soulier, J, Taghon, T, Speleman, F, Van Vlierberghe, P

Volltext

Correction: Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia von Degryse, S., de Bock, C. E., Demeyer, S., Govaerts, I., Bornschein, S., Verbeke, D., Jacobs, K., Binos, S., Skerrett-Byrne, D. A., Murray, H. C., Verrills, N. M., Van Vlierberghe, P., Cools, J., Dun, M. D.

Volltext

Longitudinal Serum Protein Analysis of Women with a High Risk of Developing Breast Cancer Reveals Large Interpatient Versus Small Intrapatient Variations: First Results from the TE... von Hagenaars, Sophie, Dekker, Lennard, Ravesteijn, Bob, van Vlierberghe, Ronald, Romijn, Fred, Verhoeff, Linda, Witkamp, Arjen, Schenk, Karin, Keymeulen, Kristien, Menke-Pluijmers, Marian, Dassen, Anneriet, Kortmann, Birgitta, de Vries, Jakob, Rutgers, Emiel, van der Burgt, Yuri, Meershoek-Klein Kranenbarg, Elma, Cobbaert, Christa, Luider, Theo, Mesker, Wilma, Tollenaar, Rob

Volltext

Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia von Degryse, S, de Bock, C E, Demeyer, S, Govaerts, I, Bornschein, S, Verbeke, D, Jacobs, K, Binos, S, Skerrett-Byrne, D A, Murray, H C, Verrills, N M, Van Vlierberghe, P, Cools, J, Dun, M D

Volltext

Location matters: spatial dynamics of tumor-infiltrating T cell subsets is prognostic in colon cancer von Zhu, Hehuan, Roelands, Jessica, Ahmed, Eiman I, Stouten, Imke, Hoorntje, Rachel, van Vlierberghe, Ronald L P, Ijsselsteijn, Marieke E, Lei, Xin, de Miranda, Noel F C C, Tollenaar, Rob A E M, Vahrmeijer, Alexander L, Bedognetti, Davide, Hendrickx, Wouter R L, Kuppen, Peter J K

Volltext

A new recurrent 9q34 duplication in pediatric T-cell acute lymphoblastic leukemia von VAN VLIERBERGHE, P, MEIJERINK, J. P. P, LEE, C, FERRANDO, A. A, LOOK, A. T, VAN WERING, E. R, BEVERLOO, H. B, ASTER, J. C, PIETERS, R

Volltext

PHF6 mutations in adult acute myeloid leukemia von Van Vlierberghe, P, Patel, J, Abdel-Wahab, O, Lobry, C, Hedvat, C V, Balbin, M, Nicolas, C, Payer, A R, Fernandez, H F, Tallman, M S, Paietta, E, Melnick, A, Vandenberghe, P, Speleman, F, Aifantis, I, Cools, J, Levine, R, Ferrando, A

Volltext

Cooperative genetic defects in TLX3 rearranged pediatric T-ALL von Van Vlierberghe, P, Homminga, I, Zuurbier, L, Gladdines-Buijs, J, van Wering, E R, Horstmann, M, Beverloo, H B, Pieters, R, Meijerink, J P P

Volltext

A method for semi-automated image analysis of HLA class I tumour epithelium expression in rectal cancer von Krijgsman, Daniëlle, Van Vlierberghe, Ronald L P, Evangelou, Vaios, Vahrmeijer, Alexander L, Van de Velde, Cornelis J H, Sier, Cornelis F M, Kuppen, Peter J K

Volltext

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy:... von Engels, C. C., Charehbili, A., van de Velde, C. J. H., Bastiaannet, E., Sajet, A., Putter, H., van Vliet, E. A., van Vlierberghe, R. L. P., Smit, V. T. H. B. M., Bartlett, J. M. S., Seynaeve, C., Liefers, G. J., Kuppen, P. J. K.

Volltext

Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia von Van Vlierberghe, P, Beverloo, H B, Buijs-Gladdines, J, van Wering, E R, Horstmann, M, Pieters, R, Meijerink, J P P

Volltext

P338: BRANCHED CHAIN AMINO ACID TRANSAMINASE 1 ASSOCIATES WITH THE KU70/KU86 HETERODIMER AND MODULATES THE DNA DAMAGE RESPONSE IN T‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA CELLS von Di Martino, L., Tosello, V., Dalla Santa, S., Papathanassiu, A., Arrigoni, G., Vlierberghe, P., Piovan, E.

Volltext

P317: TARGETING HYPERACTIVE PDGFR‐B IN T‐ALL AND T‐LBL von De Coninck, S., Van Vlierberghe, P., Goossens, S., De Smedt, R., Lintermans, B.

Volltext